vs

Side-by-side financial comparison of AGNC Investment Corp. (AGNC) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

AGNC Investment Corp. is the larger business by last-quarter revenue ($206.0M vs $197.9M, roughly 1.0× REPLIGEN CORP). AGNC Investment Corp. runs the higher net margin — 463.1% vs 6.7%, a 456.4% gap on every dollar of revenue. On growth, AGNC Investment Corp. posted the faster year-over-year revenue change (79.1% vs 13.6%). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 7.9%).

The Russell 1000 Index is a U.S. stock market index that tracks the largest 1,000 stocks in the Russell 3000 Index, which represent about 93% of the total market capitalization of that index. The index is market cap weighted, meaning larger companies have a greater influence on the index than smaller companies.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

AGNC vs RGEN — Head-to-Head

Bigger by revenue
AGNC
AGNC
1.0× larger
AGNC
$206.0M
$197.9M
RGEN
Growing faster (revenue YoY)
AGNC
AGNC
+65.5% gap
AGNC
79.1%
13.6%
RGEN
Higher net margin
AGNC
AGNC
456.4% more per $
AGNC
463.1%
6.7%
RGEN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
7.9%
AGNC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AGNC
AGNC
RGEN
RGEN
Revenue
$206.0M
$197.9M
Net Profit
$954.0M
$13.3M
Gross Margin
52.5%
Operating Margin
9.0%
Net Margin
463.1%
6.7%
Revenue YoY
79.1%
13.6%
Net Profit YoY
682.0%
143.9%
EPS (diluted)
$0.90
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AGNC
AGNC
RGEN
RGEN
Q4 25
$206.0M
$197.9M
Q3 25
$148.0M
$188.8M
Q2 25
$162.0M
$182.4M
Q1 25
$159.0M
$169.2M
Q4 24
$174.1M
Q3 24
$-64.0M
$154.9M
Q2 24
$-3.0M
$154.1M
Q1 24
$-30.0M
$151.3M
Net Profit
AGNC
AGNC
RGEN
RGEN
Q4 25
$954.0M
$13.3M
Q3 25
$806.0M
$14.9M
Q2 25
$-140.0M
$14.9M
Q1 25
$50.0M
$5.8M
Q4 24
$-30.3M
Q3 24
$346.0M
$-654.0K
Q2 24
$-48.0M
$3.3M
Q1 24
$443.0M
$2.1M
Gross Margin
AGNC
AGNC
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
AGNC
AGNC
RGEN
RGEN
Q4 25
9.0%
Q3 25
8.9%
Q2 25
7.6%
Q1 25
3.9%
Q4 24
-17.7%
Q3 24
-5.1%
Q2 24
1.0%
Q1 24
1.3%
Net Margin
AGNC
AGNC
RGEN
RGEN
Q4 25
463.1%
6.7%
Q3 25
544.6%
7.9%
Q2 25
-86.4%
8.2%
Q1 25
31.4%
3.4%
Q4 24
-17.4%
Q3 24
-540.6%
-0.4%
Q2 24
1600.0%
2.2%
Q1 24
-1476.7%
1.4%
EPS (diluted)
AGNC
AGNC
RGEN
RGEN
Q4 25
$0.90
$0.24
Q3 25
$0.72
$0.26
Q2 25
$-0.17
$0.26
Q1 25
$0.02
$0.10
Q4 24
$-0.55
Q3 24
$0.39
$-0.01
Q2 24
$-0.11
$0.06
Q1 24
$0.59
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AGNC
AGNC
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$450.0M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$12.4B
$2.1B
Total Assets
$115.1B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AGNC
AGNC
RGEN
RGEN
Q4 25
$450.0M
$767.6M
Q3 25
$450.0M
$748.7M
Q2 25
$656.0M
$708.9M
Q1 25
$455.0M
$697.2M
Q4 24
$757.4M
Q3 24
$507.0M
$784.0M
Q2 24
$530.0M
$809.1M
Q1 24
$505.0M
$780.6M
Total Debt
AGNC
AGNC
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AGNC
AGNC
RGEN
RGEN
Q4 25
$12.4B
$2.1B
Q3 25
$11.4B
$2.1B
Q2 25
$10.3B
$2.1B
Q1 25
$10.0B
$2.0B
Q4 24
$2.0B
Q3 24
$9.7B
$2.0B
Q2 24
$8.7B
$2.0B
Q1 24
$8.6B
$2.0B
Total Assets
AGNC
AGNC
RGEN
RGEN
Q4 25
$115.1B
$2.9B
Q3 25
$109.0B
$2.9B
Q2 25
$102.0B
$2.9B
Q1 25
$95.9B
$2.9B
Q4 24
$2.8B
Q3 24
$89.6B
$2.8B
Q2 24
$79.7B
$2.9B
Q1 24
$71.9B
$2.8B
Debt / Equity
AGNC
AGNC
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AGNC
AGNC
RGEN
RGEN
Operating Cash FlowLast quarter
$653.0M
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
0.68×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AGNC
AGNC
RGEN
RGEN
Q4 25
$653.0M
$25.7M
Q3 25
$153.0M
$48.1M
Q2 25
$180.0M
$28.6M
Q1 25
$192.0M
$15.0M
Q4 24
$39.2M
Q3 24
$7.0M
$49.3M
Q2 24
$-20.0M
$42.2M
Q1 24
$20.0M
$44.7M
Free Cash Flow
AGNC
AGNC
RGEN
RGEN
Q4 25
$17.6M
Q3 25
$43.4M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
Q1 24
$36.4M
FCF Margin
AGNC
AGNC
RGEN
RGEN
Q4 25
8.9%
Q3 25
23.0%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
24.3%
Q1 24
24.0%
Capex Intensity
AGNC
AGNC
RGEN
RGEN
Q4 25
4.1%
Q3 25
2.5%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
3.1%
Q1 24
5.5%
Cash Conversion
AGNC
AGNC
RGEN
RGEN
Q4 25
0.68×
1.93×
Q3 25
0.19×
3.23×
Q2 25
1.92×
Q1 25
3.84×
2.57×
Q4 24
Q3 24
0.02×
Q2 24
12.70×
Q1 24
0.05×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons